Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Pigment Dispersion Syndrome With and Without Glaucoma
Completed clinical trial evaluating pigment dispersion syndrome with and without glaucoma.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens
The National Eye Institute's clinical trial addressing abnormalities of the eye's anterior chamber, iris, cornea and lens has completed, inc…
-
CLINICAL_TRIALS research · 2008-01-02Clinical Trial Update: Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% [Phase 4]
Phase 4 clinical trial comparing brimonidine 0.1% versus brinzolamide 1% as add-ons to latanoprost 0.005% for glaucoma and ocular hypertensi…
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension [Phase 1]
A Phase 1 trial evaluating tolerability, safety, and preliminary efficacy of RKI983 eye drops in subjects with primary open-angle glaucoma a…
-
CLINICAL_TRIALS research · 2007-12-05Clinical Trial Update: Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty [NA]
A clinical trial update comparing alpha-2 adrenergic agonists to prevent intraocular pressure elevation after selective laser trabeculoplast…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-10-30FDA Approved: COMBIGAN — Original Application (Allergan, Inc.)
The FDA approved COMBIGAN, a fixed-dose combination eye drop of brimonidine tartrate and timolol maleate, under Allergan's original NDA.
-
CLINICAL_TRIALS trial_result · 2007-10-24Clinical Trial Update: Latanoprost Versus Fotil [Phase 4]
A Phase 4 trial comparing latanoprost with Fotil in open-angle glaucoma and ocular hypertension has completed.
-
FDA approval · 2007-06-08FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride) by Novartis Pharmaceuticals Corporation, updating the p…
-
FDA approval · 2007-06-08FDA Approved: TIMOLOL GFS — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for TIMOLOL GFS (timolol maleate) from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2007-06-01Clinical Trial Update: A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 multicenter study evaluating methods to reduce hyperemia associated with bimatoprost therapy for glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2007-05-21Clinical Trial Update: Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma [Phase 1, Phase 2]
Clinical trial evaluating the effect of Epigallocatechin-Gallate on inner retinal function in ocular hypertension and early open-angle glauc…
-
CLINICAL_TRIALS trial_result · 2007-02-09Clinical Trial Update: Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension [Phase 4]
Phase 4 trial comparing bimatoprost monotherapy with dual therapy using travoprost and timolol in glaucoma and ocular hypertension has compl…
-
CLINICAL_TRIALS trial_result · 2007-01-09Clinical Trial Update: Cosopt Versus Xalatan [Phase 4]
Phase 4 clinical trial comparing Cosopt (dorzolamide/timolol) with Xalatan (latanoprost) in open-angle glaucoma and ocular hypertension has …
-
FDA approval · 2006-09-28FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brinzolamide filed by Sandoz Inc to update/expand labeling.
-
FDA approval · 2006-09-21FDA Approved: TRAVATAN Z — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved TRAVATAN Z (travoprost) through an original NDA for reducing intraocular pressure in patients with open-angle glaucoma or ocula…
-
FDA approval · 2006-08-09FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
FDA approves a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) filed by Thea Pharma Inc. to update or ex…
-
CLINICAL_TRIALS trial_result · 2006-07-04Clinical Trial Update: The Efficacy of Selective Laser Trabeculoplasty
Clinical trial update on the efficacy of selective laser trabeculoplasty for glaucoma conditions, including primary open-angle glaucoma and …
-
FDA label_change · 2006-06-05FDA Approved: TIMOPTIC IN OCUDOSE — Supplemental Application (Bausch & Lomb Incorporated)
This document concerns a supplemental application for Timoptic in Ocudose (timolol maleate) filed by Bausch & Lomb Incorporated.
-
CLINICAL_TRIALS trial_result · 2006-05-24Clinical Trial Update: An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance [Phase 4]
Phase 4 clinical trial evaluating adherence to topical ocular hypotensive therapy in patients with glaucoma or ocular hypertension. The stud…
-
FDA approval · 2006-05-22FDA Approved: BRIMONIDINE TARTRATE — Original Application (Sandoz Inc)
FDA approved brimonidine tartrate ophthalmic solution through an original application by Sandoz Inc. This approval covers its use for reduci…